Key result
Pharmacist-led MTM is linked to ~37-point higher oral anticoagulant adherence scores over 8 months.
Why the study?
Deficiencies in patient knowledge and adherence impair the safety and effectiveness of oral anticoagulants, motivating an evaluation of pharmacist-led medication therapy management.
Does clinical pharmacist-led medication therapy management improve patient knowledge and adherence in patients treated with oral anticoagulants?
Cohort (n=94)
No
Does clinical pharmacist-led medication therapy management improve patient knowledge and adherence in patients treated with oral anticoagulants?
Clinical pharmacist-led medication therapy management significantly improves medication knowledge and adherence over 8 months in patients taking oral anticoagulants.
Answers are grounded in this paper and cite their sources.
Pharmacist-led MTM was associated with improved OAC knowledge and adherence; hypothesis-generating and leaves open need for RCTs.
BACKGROUND: The deficiencies in patient knowledge and adherence constitute a significant obstacle to optimal utilisation of oral anticoagulants, resulting in diminished safety and effectiveness. AIM: The aim of the study was to assess the impact of pharmacist-led medication therapy management (MTM) on knowledge and adherence outcomes in patients on oral anticoagulants. SUBJECTS AND METHODS: An observational-cohort study was conducted in the surgery, cardiology and cardiothoracic surgery departments. A clinical pharmacist trained in MTM services conducted the MTM sessions according to the guidelines. The follow-up of the patients was conducted at scheduled visits to the hospital at 0, 4 and 8 months. The knowledge and adherence outcomes were assessed through a repeated measures analysis of variance, with P < 0.05 was statistically significant. RESULTS: Out of 100 patients, 94 patients were followed up on, and their data were analysed. The commonly prescribed oral anticoagulants were acenocoumarol (34%) and warfarin (29%). The baseline knowledge and adherence scores on oral anticoagulant medications were 43.40 ± 19.37 and 51.59 ± 25.34. The MTM services were provided after 4-month and 8-month intervals, knowledge scores were 71.38 ± 14.99 and 82.97 ± 9.92, and the adherence scores were 80.45 ± 11.95 and 88.56 ± 9.64, respectively. Thirty-four adverse drug reactions were reported, with an International Normalized Ratio range >6 for which anticoagulation reversal agents were used. CONCLUSION: The clinical pharmacist-led MTM services significantly improved knowledge ( P < 0.001) and adherence ( P < 0.001) of patients treated with oral anticoagulants at different time intervals. The pharmacist's role in anticoagulation management service will be helpful for physicians to optimise and maintain the dose.
No takes yet. Share an insight, caveat, or question.
Vooradi et al. (2026) conducted a cohort in Oral anticoagulant use (n=94). Pharmacist-led medication therapy management (MTM) vs. Baseline (pre-MTM scores at 0 months) was evaluated on Patient knowledge and adherence scores on oral anticoagulant medications at 0, 4, and 8 months (p=<0.001). Pharmacist-led MTM significantly improved patient knowledge (43.40 to 82.97, P<0.001) and adherence (51.59 to 88.56, P<0.001) scores on oral anticoagulants over 8 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: